CareTalk: Healthcare. Unfiltered. · 2026-04-10 · 25 min
Send us Fan Mail One in six children has a developmental delay, and it takes an average of five years to get a diagnosis for a genetic disease. But it doesn't have to. The technology to get answers in 48 hours already exists. Katherine Stueland, CEO, GeneDx joins host John Driscoll to discuss why rare genetic diseases are far more common than most people realize, how whole genome sequencing is transforming pediatric care, and what it will take to bring precision medicine to every child who needs it. ️️ABOUT KATHERINE STUELAND Katherine Stueland has dedicated her career to transforming healthcare by leading patient-centric businesses. Her career has spanned supporting the FDA approval of several rare disease therapeutics, the first protease inhibitor for HIV/AIDS and the first cancer immunotherapy, all in partnership with the powerful voices of patient advocates. Katherine has been a central figure in moving healthcare forward by integrating genomic information to enhance the accuracy and effectiveness of diagnosing cancer and rare diseases.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Episode: 200 - Ridhi Tariyal on Bridging the Data Gap in Women’s HealthMedtech Talk · on Genomics87 / 100
Navigating High-Cost Claims: Employer Strategies for Managing Complex Healthcare Cases with Dr. Christine Hale, Chief Medical Officer, US Benefits at GallagherThe Benefits Playbook · on healthcare85 / 100
How Healthcare Moves from Reactive Care to Preventive with Ray PawlickiBiology Matters · on Precision medicine83 / 100
Success Leaves Clues: Ep 296 How Healthcare Innovation Improves Patient Access with John Leombruno, CEO at OkRx Success Leaves Clues with Robin Bailey and Al McDonald · on healthcare podcast79 / 100
Healthcare AI Is Failing And the Fix Isn't More DataSaaS That App · on Precision medicine73 / 100
The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, NateraProgress, Potential, and Possibilities Podcast / Show · on Precision medicine65 / 100
AI and The Future Of Behavioral Health w/ Alon Joffe, Co-Founder & CEO, Eleos Health88 / 100
How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio Therapeutics94 / 100
Preparing for the Pandemic We Haven't Seen Yet w/ Dr. Dan Barouch & Kris Brown, Vector Sciences87 / 100Mark Cuban on Why Patients Don’t Trust Their Medical Bills85 / 100
Why Healthcare Prices Are Like Fight Club w/ Mark Cuban, Co-Founder, Cost Plus Drugs100 / 100